Purchase Order 75N93025P00144
Award Date
12/19/24
Potential Completion Date
5/24/25
Potential Value
$24K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Hamilton, MT 59840, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. The $93,525.44 contract provides a 12-month silver support plan for two NextSeq 2000 sequencing systems. No set-aside was used. Illumina is a manufacturer and provider of genomic analysis instruments and reagents, and has previously received prime federal contracts and sub-awards from the NIH, CDC,...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Illumina, Inc. for a NextSeq 2000 Silver Support Plan. The contract has a ceiling value of $32,657.70 and a period of performance through July 4, 2025. Illumina is a manufacturer of sequencing and genomic analysis instruments and has been awarded other federal prime contracts and subcontracts to provide sequencing systems, reagents, and services to support...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract provides a MiSeq Silver Support Plan with a ceiling value of $13,250.00 and an ultimate completion date of January 2, 2021. Illumina has a long history of providing sequencing systems and related products and services to support research and diagnostics across...
This is a $41,061.69 firm fixed-price purchase order awarded to Illumina, Inc. by the National Institute of Allergy and Infectious Diseases (NIAID) for a NEXTSEQ 500 and MISEQ service agreement. The contract has a period of performance through February 27, 2025. Illumina is a manufacturer of genetic sequencing instruments and reagents that has previously provided similar products and services to support genomic research and diagnostics across various federal agencies. This award does not...
This is a $16,198 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc. for a MiSeq Silver Support Plan with an ultimate completion date of February 5, 2026. Illumina is a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis, and has been awarded previous prime contracts and subcontracts by federal...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. government, to Illumina, Inc. for a service agreement for a NextSeq 2000 sequencing system. The total ceiling value of the contract is $48,209.00 and it has an ultimate completion date of December 15, 2025. This contract does not have a set-aside designation. Illumina is a manufacturer of genomic sequencing instruments and reagents, and...
This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc. for a renewal service agreement to support two Illumina NextSeq sequencing systems. The contract has a ceiling value of $74,756.41 and a period of performance through March 20, 2026. There is no set-aside designation for this award. Illumina is a manufacturer of genomic sequencing...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The $24,999 contract is for a NEXTSEQ 2000 BRONZE SUPPORT PLAN (AMBIS 2259765) with a performance period through July 11, 2026. The contract does not utilize any set-aside designation. Illumina has been awarded numerous federal contracts and grants by agencies...
This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract is for the basic product care maintenance of a NextSeq S/N NSS00515 sequencing system, including a 4-year service plan. The total ceiling value of the contract is $137,565.03. Illumina, a manufacturer of DNA sequencing instruments and reagents, has previously received other prime...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order to Illumina, Inc. for a NEXTSEQ 2000 SILVER SUPPORT PLAN. The potential value of the contract is $48,209.00, with a completion date of April 2, 2025. This contract is not set aside and is for the provision of sequencing and array-based solutions to support genomic analysis and life science research. Illumina, a for-profit...